Phoenix loses Finance Director
Phoenix Group said its Finance Director, Jonathan Yates, is to leave the closed life assurance fund consolidator at the end of February of next year.
Phoenix Group said its Finance Director, Jonathan Yates, is to leave the closed life assurance fund consolidator at the end of February of next year.
Yates, who has been appointed Chief Executive at Guardian Financial Services, has been with Phoenix for 18 months.
His deputy, Paul Miles, will take over on an acting basis with immediate effect while the board searches for a permanent replacement.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company said it is set to generate around £800m of cash at the operating company level in 2011, slap bang in the middle of its stated target range, and up from last year's £734m.
"As a closed life fund company, cash generation is our key metric," said Phoenix Chief Executive Clive Bannister, as he hailed the achievement of generating £800m as a "significant achievement".
Phoenix, consolidates closed life funds and then manages them through its subsidiary Ignis Asset Management. It currently has £68bn under management.
Phoenix shares have fallen by 17% so far this year.
BS/JH
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published